期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Acta Neuropathologica Communications LetPub Score 7.2
50 ratings
Rate
Reputation 8.3 Influence 6.5 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | ACTA NEUROPATHOL COM | ||||||||||||||||||||||||
ISSN | 2051-5960 | ||||||||||||||||||||||||
h-index | 37 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 3.20%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://www.springer.com/journal/40478 | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/ANEC | ||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||
出版商 | BioMed Central | ||||||||||||||||||||||||
主題領域 | Medicine | ||||||||||||||||||||||||
出版國/地區 | United Kingdom | ||||||||||||||||||||||||
發行頻率 | |||||||||||||||||||||||||
創刊年 | 2013 | ||||||||||||||||||||||||
每年文章數 | 192每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 100.00% | ||||||||||||||||||||||||
OA Related Info | APC: Yes( GBP2790; USD3590; EUR3090; ) APC waiver:Check Notes Other charges: No Keywords: pathology、nervous system、skeletal muscle disorders、neurological disease Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2051-5960%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 8 Weeks | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Acta Neuropathologica Communications] 的評論 | 撰寫評論 |
作者: 深渊笑薇 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-28 09:40:25 評論於 That option is optional and can be left unselected.(0) 讚! | 深渊笑薇 |
作者: 极乐语林 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-25 20:59:12 評論於 Does the submission process not include the "with editor" stage, so that once a submission is made, it is automatically marked as "Under Review"?(0) 讚! | 极乐语林 |
作者: 极乐语林 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-25 18:25:48 評論於 Is the status of this magazine "Under Review" an internal audit?(0) 讚! | 极乐语林 |
作者: 极乐语林 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-25 10:15:15 評論於 I want the original image, unedited, but there is no requirement for the full resolution, no need to submit three times(0) 讚! | 极乐语林 |
作者: 風見醉芙 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-24 23:27:47 評論於 Do you need the original images for Wb, or is it okay to use cropped ones? Should each band be repeated three times?(0) 讚! | 風見醉芙 |
作者: Mortimer Grace 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-11 19:03:23 評論於 Please translate the following paragraph into English and Japanese(0) 讚! | Mortimer Grace |
作者: Mortimer Grace 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-11 17:51:30 評論於 Please translate the following paragraph into English and Japanese, and title them as ":" and ":"(0) 讚! | Mortimer Grace |
作者: Mortimer Grace 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-05 10:13:19 評論於 Preparing to submit a manuscript(0) 讚! | Mortimer Grace |
作者: 墟散殿原 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-01 12:33:49 評論於 Review Speed: 1.0 | Submission Hit Rate: 25.0 Emphasis on Research Direction: Mechanism of AD Pathogenesis Experience Sharing: Very friendly journal, high-quality articles, focusing on research on the pathogenesis of neurological diseases. The reviewers are also very friendly, providing many valuable suggestions(0) 讚! | 墟散殿原 |
作者: 珉林语蓝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-27 08:47:45 評論於 OP, how did you finally choose? I recently encountered the same issue and there doesn't seem to be an option to disagree. If you choose to agree, will there be a pre-print?(0) 讚! | 珉林语蓝 |
作者: 一吃就胖小修谨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-08 10:20:24 評論於 I would like to ask, when submitting to this journal, what impact does the Research Square author dashboard have? Will it generate a pre-print? Because pre-print is an irreversible step(0) 讚! | 一吃就胖小修谨 |
作者: 一吃就胖小修谨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-07 10:23:03 評論於 I would like to ask whether the Research Square author dashboard step in the submission process of this journal will generate a pre-print. Pre-prints are troublesome as they cannot be withdrawn. The only option available is to agree, with no other choices. What negative consequences will arise from selecting to agree? Thank you for clarifying(0) 讚! | 一吃就胖小修谨 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:45:11 評論於 You may choose not to include it, but make sure to provide convincing reasons for the reviewers and editors(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 18:23:58 評論於 Issues related to experiments and article writing(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 20:21:29 評論於 What questions do reviewers and journal editors typically ask?(0) 讚! | 八坂篷蔚 |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 13:40:52 評論於 Do reviewers and journal editors require me to conduct additional experiments? Is it absolutely necessary to conduct them?(0) 讚! | 平原文波 |
作者: Werner Pope 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-04-14 08:05:13 評論於 Hello, I would like to inquire if this magazine has high requirements for innovation?(0) 讚! | Werner Pope |
作者: Candice Cotton 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-01-28 16:39:04 評論於 Review speed: 1.0 | Submission acceptance rate: 25.0 Sharing experience: A very good journal, received minor revisions after the first review in 39 days. Although they were minor revisions, the reviewers were really meticulous, providing more than 30 comments in total. After revising and resubmitting in 12 days, the paper was accepted in 3 days(0) 讚! | Candice Cotton |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us